Dronedarone and captisol-enabled amiodarone in an experimental cardiac arrest

Journal of Cardiovascular Pharmacology

Volumn 61, Issue 5, 2013, Pages 385-390

  Glover, Benedict M ^a,b   Hu, Xudong ^a,b   Aves, Theresa ^a,b   Ramadeen, Andrew ^a,b   Zou, Lily ^a,b   Leong Poi, Howard ^a,b   Fujii, Hiroko ^a,b   Dorian, Paul ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA CYCLODEXTRIN SULFOBUTYL ETHER; DRONEDARONE; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA PRESSURE; ARTICLE; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; HEART ARREST; HEART VENTRICLE FIBRILLATION; HEMODYNAMIC MONITORING; HYPOTENSION; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RESUSCITATION; SURVIVAL; SWINE;

AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; BLOOD PRESSURE; CARDIOPULMONARY RESUSCITATION; DISEASE MODELS, ANIMAL; ELECTRIC COUNTERSHOCK; HEART ARREST; HEART RATE; SWINE; VENTRICULAR FIBRILLATION;

EID: 84877609543     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3182868750     Document Type: Article

References (19)

1. Dorian P, Cass D, Schwartz B, et al. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med. 2002;346:884-890.
2. Kudenchuk PJ, Cobb LA, Copass MK, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med. 1999;341:871-878.
3. Neumar RW, Otto CW, Link MS, et al. Adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2010;122:S729-S767.
4. Fain ES, Lee JT, Winkle RA. Effects of acute intravenous and chronic oral amiodarone on defibrillation energy requirements. Am Heart J. 1987; 114:8-17.
5. Frame LH. The effect of chronic oral and acute intravenous amiodarone administration on ventricular defibrillation threshold using implanted electrodes in dogs. Pacing Clin Electrophysiol. 1989;12:339-346.
6. Kowey PR, Levine JH, Herre JM, et al The Intravenous Amiodarone Multicenter Investigators Group. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. Circulation. 1995;92:3255-3263.
7. Levine JH, Massumi A, Scheinman MM, et al Intravenous Amiodarone Multicenter Trial Group. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. J Am Coll Cardiol. 1996;27: 67-75.
8. Cushing DJ, Kowey PR, Cooper WD, et al. PM101: a cyclodextrin-based intravenous formulation of amiodarone devoid of adverse hemodynamic effects. Eur J Pharmacol. 2009;607:167-172.
9. Varró A, Takács J, Németh M, et al. Electrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: comparison with amiodarone. Br J Pharmacol. 2001;133: 625-634.
10. Finance O, Manning A, Chatelain P. Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D, L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. J Cardiovasc Pharmacol. 1995;26:570-576.
11. Manning AS, Bruyninckx C, Ramboux J, et al. SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats. J Cardiovasc Pharmacol. 1995;26: 453-461.
12. Rochetaing A, Barbe C, Kreher P. Beneficial effects of amiodarone and dronedarone (SR 33589b), when applied during low-flow ischemia, on arrhythmia and functional parameters assessed during reperfusion in isolated rat hearts. J Cardiovasc Pharmacol. 2001;38:500-511.
13. Shaaraoui M, Freudenberger R, Levin V, et al. Suppression of ventricular tachycardia with dronedarone: a case report. J Cardiovasc Electrophysiol. 2011;22:201-202.
14. Fink A, Duray GZ, Hohnloser SH. A patient with recurrent atrial fibrillation and monomorphic ventricular tachycardia treated successfully with dronedarone. Europace. 2011;13:284-285.
15. Agelaki MG, Pantos C, Korantzopoulos P, et al. Comparative antiarrhythmic efficacy of amiodarone and dronedarone during acute myocardial infarction in rats. Eur J Pharmacol. 2007;564:150-157.
16. van Opstal JM, Schoenmakers M, Verduyn SC, et al. Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome. Circulation. 2001;104: 2722-2727.
17. Køber L, Torp-Pedersen C, McMurray JJ, et al Dronedarone Study Group. Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med. 2008;358:2678-2687.
18. Chatterjee S, Ghosh J, Lichstein E, et al. Meta-analysis of cardiovascular outcomes with dronedarone in patients with atrial fibrillation or heart failure. Am J Cardiol. 2012;110:607-613.
19. Connolly SJ, Camm AJ, Halperin JL, et al PALLAS Investigators. Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med. 2011; 365:2268-2276.